API – Under Development
| Sr. No. | Product Name | Therapeutic Category | Sample |
|---|---|---|---|
1 |
Brivaracetam | Anti-convulsant |
Available |
2 |
Dabigatran Etexilate Mesylate | Anti-coagulant |
Available |
3 |
Edoxaban Tosylate Monohydrate | Anti-coagulant |
Available |
4 |
Imeglimin Hydrochloride | Anti-diabetic |
Available |
5 |
Mirogabalin Besylate | Diabetic Neuropathy |
Available |
6 |
Pitavastatin Calcium | Anti-hyperlipidemic |
Available |
7 |
Safinamide Mesylate | Anti-Parkinson |
Available |
8 |
Sitagliptin Phosphate Monohydrate | Anti-diabetic |
Available |
Disclaimer: CTX Lifesciences respects patent laws and conventions of pharmaceuticals as applicable in different countries.
API/Substances covered by patent are not offered to the countries where the patent law is in force. However, the final responsibility lies with the customer.